Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 2/20 | 0.33 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.32 |
| ▸ | ABL1 | P00519 | 1/20 | 0.31 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.31 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.31 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.30 |
| ▸ | ITGAV | P06756 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14066100 | 0.88 | — | — | |
| SCHEMBL14066106 | 0.88 | ABL1 (0.31) | ABL1RIN1 | |
| SCHEMBL14066099 | 0.84 | ITGB3 (0.32) | ITGB3ITGAV | |
| SCHEMBL14066105 | 0.81 | ABL1 (0.33) | P2RY6ABL1RIN1 | |
| SCHEMBL802564 | 0.71 | PRMT6 (0.38) | — | |
| SCHEMBL14066088 | 0.71 | HTR2C (0.32) | — | |
| SCHEMBL22983967 | 0.69 | ABL1 (0.37) | P2RY6ABL1RIN1 | |
| SCHEMBL1101373 | 0.67 | PRMT6 (0.39) | — | |
| SCHEMBL19305221 | 0.67 | P2RY6 (0.38) | P2RY6USP30ABL1RIN1ITGB3 | |
| SCHEMBL14853866 | 0.66 | ABL1 (0.38) | P2RY6ABL1RIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7427672-B2 | Artificial nucleic acids of n-o bond crosslinkage type | Imanishi, Takeshi (JP) | 2008-09-23 | — | — | US | disclosed |
| US-20070167387-A1 | Novel artificial nucleic acids of n-o bond crosslinkage type | TAKESHI IMANISHI (JP) | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167387-A1 | Novel artificial nucleic acids of n-o bond crosslinkage type | RNGTT, NSUN2, POLR2H | P2RY6 3418/4885USP30 2553/4885ABL1 3995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.